Literature DB >> 30725269

[Hematological-oncological intensive care patients : Treatment without borders].

M Kochanek1,2,3, A Shimabukuro-Vornhagen4,5, B Böll4,5.   

Abstract

The number of treatment options and success of treating patients with cancer have both significantly increased in recent years. However, many of these patients require intensive care due to comorbidities, treatment-associated complications, or severe infections. At the same time, the boundaries between what is feasible and sensible are difficult to draw. Over the past few years, awareness of the problems these cancer patients may have in the intensive care unit has increased and discussions have begun. This article intends to offer a discussion basis and also possible solution strategies.

Entities:  

Keywords:  Cancer; Hematology; Intensive care; Medical oncology; Triage

Mesh:

Year:  2019        PMID: 30725269     DOI: 10.1007/s00063-019-0532-4

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  27 in total

1.  Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit.

Authors:  T Staudinger; B Stoiser; M Müllner; G J Locker; K Laczika; S Knapp; H Burgmann; A Wilfing; J Kofler; F Thalhammer; M Frass
Journal:  Crit Care Med       Date:  2000-05       Impact factor: 7.598

2.  Everything that should be done--not everything that can be done.

Authors:  D P Schuster
Journal:  Am Rev Respir Dis       Date:  1992-03

3.  Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: a single center experience.

Authors:  Peter Schellongowski; Thomas Staudinger; Michael Kundi; Klaus Laczika; Gottfried J Locker; Andja Bojic; Oliver Robak; Valentin Fuhrmann; Ulrich Jäger; Peter Valent; Wolfgang R Sperr
Journal:  Haematologica       Date:  2010-11-11       Impact factor: 9.941

4.  An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses.

Authors:  Paul N Lanken; Peter B Terry; Horace M Delisser; Bonnie F Fahy; John Hansen-Flaschen; John E Heffner; Mitchell Levy; Richard A Mularski; Molly L Osborne; Thomas J Prendergast; Graeme Rocker; William J Sibbald; Benjamin Wilfond; James R Yankaskas
Journal:  Am J Respir Crit Care Med       Date:  2008-04-15       Impact factor: 21.405

5.  Changing use of intensive care for hematological patients: the example of multiple myeloma.

Authors:  E Azoulay; C Recher; C Alberti; L Soufir; G Leleu; J R Le Gall; J P Fermand; B Schlemmer
Journal:  Intensive Care Med       Date:  1999-12       Impact factor: 17.440

6.  Cancer survivors--United States, 2007.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2011-03-11       Impact factor: 17.586

7.  Long-term survival from respiratory failure after marrow transplantation for malignancy.

Authors:  S W Crawford; F B Petersen
Journal:  Am Rev Respir Dis       Date:  1992-03

8.  Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit.

Authors:  Frédéric Pène; Stéphanie Percheron; Virginie Lemiale; Vivian Viallon; Yann-Erick Claessens; Sophie Marqué; Julien Charpentier; Derek C Angus; Alain Cariou; Jean-Daniel Chiche; Jean-Paul Mira
Journal:  Crit Care Med       Date:  2008-03       Impact factor: 7.598

9.  Prognosis of hematologic malignancies does not predict intensive care unit mortality.

Authors:  Paul B Massion; Alain M Dive; Chantal Doyen; Pierre Bulpa; Jacques Jamart; André Bosly; Etienne Installé
Journal:  Crit Care Med       Date:  2002-10       Impact factor: 7.598

10.  Intensive care of the cancer patient: recent achievements and remaining challenges.

Authors:  Elie Azoulay; Marcio Soares; Michael Darmon; Dominique Benoit; Stephen Pastores; Bekele Afessa
Journal:  Ann Intensive Care       Date:  2011-03-23       Impact factor: 6.925

View more
  1 in total

1.  Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis.

Authors:  Panagiotis Karagiannis; Lena Sänger; Winfried Alsdorf; Katja Weisel; Walter Fiedler; Stefan Kluge; Dominic Wichmann; Carsten Bokemeyer; Valentin Fuhrmann
Journal:  Cancers (Basel)       Date:  2020-06-24       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.